Hypobetalipoproteinaemia secondary to chronic hepatitis C virus infection in a patient with familial hypercholesterolaemia

Ann Clin Biochem. 2009 Sep;46(Pt 5):420-2. doi: 10.1258/acb.2009.009004. Epub 2009 Jun 1.

Abstract

Familial hypercholesterolaemia (FH) is a common genetic disorder characterized by high plasma low-density lipoprotein (LDL)-cholesterol and premature coronary artery disease. Many factors, such as illness, high-dose statin therapy or a strict vegan diet can cause hypobetalipoproteinaemia (HBL). The more common secondary causes of HBL in the hospital setting include cachexia, intestinal malabsorption, malnutrition, severe liver disease and hyperthyroidism. We report a case of HBL in a 43-year-old man with previously demonstrated marked hypercholesterolaemia who attended a lipid disorders clinic for FH cascade screening. Surprisingly, a lipid profile taken at that time showed low plasma LDL-cholesterol and apolipoprotein B concentrations of 1.6 mmol/L and 0.61 g/L, respectively. He was not on lipid-lowering therapy. DNA sequencing showed that he was heterozygous for the LDLR gene mutation (C677R) present in other affected family members. Of interest, his serum transaminases were increased by approximately 3-fold and hepatitis serology and genotyping confirmed a diagnosis of hepatitis C virus (HCV) infection. In summary, we describe a case of HBL secondary to chronic HCV infection in a patient with FH, confirmed by mutational analysis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • DNA Mutational Analysis
  • Hepatitis C, Chronic / complications*
  • Hepatitis C, Chronic / metabolism
  • Hepatitis C, Chronic / pathology
  • Hepatitis C, Chronic / physiopathology
  • Heterozygote
  • Humans
  • Hypercholesterolemia / complications*
  • Hypercholesterolemia / genetics
  • Hypercholesterolemia / pathology
  • Hypercholesterolemia / physiopathology*
  • Hyperlipoproteinemia Type II / etiology*
  • Hyperlipoproteinemia Type II / genetics
  • Hyperlipoproteinemia Type II / pathology
  • Hyperlipoproteinemia Type II / physiopathology*
  • Male
  • Receptors, LDL / genetics

Substances

  • Receptors, LDL